Edge Wealth Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Edge Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 21, 2020	SELL	$39.09 - $53.44 $7,818 - $10,688	-200 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$46.7 - $92.04 $9,340 - $18,408	200 New	200 $10,000
Q1 2020 Apr 20, 2020	SELL	$48.35 - $118.68 $14,505 - $35,604	-300 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$57.36 - $124.1 $17,208 - $37,230	300 New	300 $37,000
Q1 2018 Apr 05, 2018	SELL	$52.72 - $67.25 $39,540 - $50,437	-750 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$58.2 - $72.76 $26,190 - $32,742	450 Added 150.0%	750 $44,000
Q3 2017 Oct 19, 2017	BUY	$57.01 - $118.75 $17,103 - $35,625	300	300 $18,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.